Parkway Life Real Estate Investment TrustSGX: C2PU

Sreit Corporate Day 7 November 2024

· Issued by Parkway Life Real Estate Investment Trust

("PLife REIT")

Investors Presentation

7 November 2024

1

Disclaimer

This document is for information only and does not constitute an invitation or offer to acquire, purchase or subscribe for units in Parkway Life Real Estate Investment Trust ("Parkway Life REIT" and the units in Parkway Life REIT, the "Units").

The value of the Units and the income derived from them may fall as well as rise. The Units are not obligations of, deposits in, or guaranteed by, Parkway Trust Management Limited, as manager of Parkway Life REIT (the "Manager") or any of its affiliates. An investment in Units is subject to investment risks, including the possible loss of the principal amount invested.

Investors have no right to request the Manager to redeem their Units while the Units are listed. It is intended that Unitholders of Parkway Life REIT may only deal in their Units through trading on Singapore Exchange Securities Trading Limited (the "SGX-ST"). Listing of the Units on SGX-ST does not guarantee a liquid market for the Units.

The past performance of Parkway Life REIT or the Manager is not necessarily indicative of the future performance of Parkway Life REIT or the Manager.

This document may contain forward-looking statements that involve assumptions, risks and uncertainties. Actual future performance, outcomes and results may differ materially from these forward-looking statements as a result of a number of risks, uncertainties and assumptions. Representative examples of these factors include (without limitation) general industry and economic conditions, interest rate trends, cost of capital and capital availability, competition, shifts in expected levels of property rental income, changes in operating expenses, property expenses, governmental and public policy changes and the continued availability of financing in the amounts and on the terms necessary to support Parkway Life REIT's future business. Investors are cautioned not to place undue reliance on these forward-looking statements, which are based on the Manager's current view of future events.

2

("PLife REIT")

1

Key Highlights

2

Financial Performance

Agenda

3

4

Property Portfolio

Growth Strategy

  • Capital & Financial Management
  • Appendix (Property Information)

3

Key Highlights

4

Gross Revenue for YTD 3Q 2024

  • Declined by 2.2% mainly due to depreciation of JPY, partly offset by contribution from the properties acquired in 2023 and 2024

S$108.5 million 2.2%

DPU Growth Y-o-Y

  • As the REIT has hedged the net income from Japan, the drop in revenue will be compensated by the FX gains from the settlement of the forward contracts
  • Higher distributable income from Singapore hospitals and some Japanese nursing homes with step-up lease arrangements
  • DPU for YTD 2024 (3Q DPU to be distributed as part of 2H 2024 distribution)

11.30 cents1

2.8%

%

Strong Balance Sheet & Capital Structure2

Low all-in debt cost

Gearing

Interest cover

1.36%

37.5%

10.2 times3

  1. Effect of recognising rental income on a straight-line basis over the lease term of the investment properties i.e. effective rent. There is no distribution impact arising from effective rent treatment
  2. As at 30 September 2024
  3. Applicable to Adjusted-ICR as prescribed under the MAS' Property Funds Appendix. PLife REIT has no hybrid securities as of reporting date

5

Strengthens Japan Portfolio with Acquisition of a Newly-built Nursing Home Property in August 2024

  • Acquisition of a new and quality nursing home at JPY2,446.2 million (S$20.7 million)1 in Osaka at approximately 9.1% below valuation
  • Fortify strategic partnership with K.K. FDS, an established real estate developer, in a second collaboration and deepening working relationship with an existing credible tenant, K.K. BISCUSS

Secured Long-Term Committed Loans for Pre-emptive Refinancing of Near-Term Debts

  • Successfully put in place two 7-year JPY loans to refinance the maturing loans due in 2025 and term out the short-term loan drawn down for acquisition, by 4Q 2024
  • Post refinancing, no long-term debt refinancing needs till September 2026
  • Overall weighted average debt term will extend from 3.0 years2 to 3.8 years upon drawdown of the new loan facilities

On-going Management of PLife REIT's Financial Risks

    • Principal FX risk mitigated as JPY acquisitions are fully funded by JPY loans (natural hedge)
    • Income FX risk mitigated with JPY net income hedges in place till 1Q 2029
    • Executed several interest rate swaps in 3Q 2024 (including forward-starting swaps) to extend maturing hedges for another 4 to 7 years
    • As at 30 September 2024, about 87% of interest rate exposure is hedged
  1. At an exchange rate of S$1.00 = JPY117.92
  2. As at 30 September 2024

6

Expected
Completion
Date
Seller
Purchase Price
Method of
Financing
Pro Forma
Financial
Effects (FY23)5

Acquisition of 11 Nursing Homes in France (1/2)

Strategic Foray into a Third Key Market Through the France Acquisition

  • Acquisition of 11 nursing homes in France from the DomusVi Group1, one of the largest providers of nursing home services in Europe
  • Third key market in Europe & UK presents strong fundamentals, growing aging population and aged care sectors
  • France, the second largest economy in Eurozone by GDP with opportunities for consolidation in the aged care market
  • Favourable lease terms under a sale and leaseback arrangement of 12 years2

Acquisition

Rationale

Capturing structural trends in France's nursing home sector

High quality portfolio of assets that complements and strengthens PLife REIT's portfolio

Forging a long-term strategic partnership with a leading Pan-European operator

Further rejuvenation and diversification of

PLife REIT's portfolio

Attractive value proposition with DPU and

NAV per unit accretion

Transaction Summary

DomusVi Group1

€111.2m (S$159.9m)3

Properties were independently valued by Cushman & Wakefield Valuation France at S$165.8m3 as at 30 September 2024

Fully funded by maiden equity fund raising4 by way of a private placement

DPU accretion of 1.5%

NAV per unit accretion of 4.3%

4Q2024

1.

DomusVi Group refers to DomusVi and its subsidiaries

2.

Lease terms of the Properties include indexed rent escalations

3.

Based on the assumed exchange rate of €1 to S$1.43728

4.

Please refer to the announcement titled "Launch of Equity Fund Raising By Way Of a Private Placement to Raise Gross Proceeds of No Less Than Approximately

7

S$180.0 million" for further details

5.

Pro Forma financial effects of the transaction based on the issue of approximately 47.4 million Placement Units at the Issue Price of S$3.80 per Placement Unit

Acquisition of 11 Nursing Homes in France (2/2)

Strategically Located Nursing Homes Backed by Favourable Lease Terms

88

61

1

73

10

11

Grand Est

76

2

Normandie

Bourgogne-Franche-Comté

3

55

Paris

4

73

9

Nouvelle-

83

Auvergne-

Aquitaine

5

Rhône-Alpes

8

82

7

83

72

104

6

Occitanie

Key Highlights

11

Nursing Homes1 Well- Located across France

100%

Committed Occupancy

850

Beds

12

Years Lease Term2

No. of Beds

8

1. The Properties are freehold

2. Lease terms of the Properties include indexed rent escalations

Financial Performance

9

YTD 3Q 2024 Revenue and NPI Composition

Gross Revenue (S$'000)

Net Property Income (S$'000)

Japan Portfolio 32,080

Malaysia Portfolio

208

Total Revenue

108,475 Singapore Portfolio1 76,187

Malaysia Portfolio

112

Japan

Portfolio

28,826Total NPI

102,352

Singapore

Portfolio1

73,414

Gross Revenue (Overall Portfolio)

116,000

112,000110,890

108,475

108,000

104,000

100,000

YTD 3Q 2023 YTD 3Q 2024

Net Property Income (Overall Portfolio)

110,000

106,000104,548

102,352

102,000

98,000

94,000

90,000

YTD 3Q 2023 YTD 3Q 2024

10

1. Singapore Portfolio comprises Mount Elizabeth Hospital, Gleneagles Hospital and Parkway East Hospital

Company analysis